{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:45:29Z","timestamp":1791852329898,"version":"4.3.4"},"posted":{"date-parts":[[2025,4,29]]},"group-title":"In Review","reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,2,4]]},"abstract":"<title>Abstract<\/title>\n        <p>HTLV-1 is an enigmatic retrovirus triggering a debilitating neuroinflammatory disease, HTLV-1-associated myelopathy (HAM), with unknown pathogenesis. Both HTLV-1 infection and HAM predominantly affect women and non-white neglected populations. HAM is lacking disease-modifying treatment, as current treatment is mostly symptomatic and inspired by either HIV-1 or multiple sclerosis therapeutic strategies. We used systems biology analyses of novel and publicly available data comprising (epi)genomics, transcriptomics, metabolomics and proteomics of multi-ancestry cohorts from a total of &gt;\u20092500 People Living with HTLV-1 from 5 countries (Brazil, Peru, Japan, UK, US). Leveraging an unique admixed Brazilian cohort, genome-wide association study (GWAS) revealed African-specific variants in inflammasome sensor <italic>AIM2<\/italic> with genome-wide significance (p\u2009&lt;\u20095x10<sup>\u2212\u20098<\/sup>). Suggestive loci (p\u2009&gt;\u20095x10<sup>\u2212\u20098<\/sup>) corresponding to metabolic, immune and neuronal genes were validated using published Japanese GWAS. Polygenic risk score and proviral load were independent disease predictors across ancestries. Systems biology analysis revealed neuronal\/synaptic signaling, monocyte count, glucose\/lipid metabolism, and neurocognition\/depression as genetically linked to HAM. <italic>In silico<\/italic> drug screening identified estrogen blocker Fulvestrant as the top hit, while also confirming existing (pre)clinical data for HDAC inhibitors and immunosuppressants. Validated GWAS genes were overexpressed in HAM patients\u2019 whole blood and CD4 T-cells, as well as in spinal cord astrocytes, oligodendrocytes, and microglia by single-cell RNAseq. We experimentally confirmed decreased ApoA1\/lipid\/cholesterol levels, higher monocyte levels and lower neurocognitive scores in multi-ancestry cohorts. We found striking biological similarities between retroviral Hbz\/Tax overexpression, Hbz interactome and HAM multi-omics findings: enrichment for lipid\/cholesterol metabolism, estrogen signaling, neurodegenerative diseases, and viral pathways including EBV, recently identified as the major driver of multiple sclerosis. In conclusion, our data-driven approach uncovers novel disease mechanisms and therapeutic targets, and a validated polygenic risk score allowing targeted surveillance for high-risk individuals. A strong molecular overlap to other neurodegenerative\/neuroinflammatory diseases reveals shared neuropathogenic pathways between unrelated viruses.<\/p>","DOI":"10.21203\/rs.3.rs-5960764\/v1","type":"posted-content","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:53:31Z","timestamp":1745906011000},"source":"Crossref","is-referenced-by-count":4,"title":["Multi-cohort cross-omics analysis reveals disease mechanisms and therapeutic targets in HTLV-1-associated myelopathy, a neglected retroviral neuroinflammatory disorder"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3234-8426","authenticated-orcid":false,"given":"Johan Van","family":"Weyenbergh","sequence":"first","affiliation":[{"name":"KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane","family":"Assone","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina\/USP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6108-9566","authenticated-orcid":false,"given":"Isaac","family":"Racine","sequence":"additional","affiliation":[{"name":"Laboratory for Complex Genetics, Department of Human Genetics\/KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4519-8682","authenticated-orcid":false,"given":"Soraya","family":"Menezes","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina \/ Universidade de Sao Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0114-7587","authenticated-orcid":false,"given":"V\u00edctor","family":"Folgosi","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo Medical School - USP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Marcusso","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases \u201cEmilio Ribas\u201d \/ Secretaria de Sa\u00fade do Estado de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Haziot","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases \u201cEmilio Ribas\u201d \/ Secretaria de Sa\u00fade do Estado de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerusa","family":"Smid","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases \u201cEmilio Ribas\u201d \/ Secretaria de Sa\u00fade do Estado de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Dahy","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases \u201cEmilio Ribas\u201d \/ Secretaria de Sa\u00fade do Estado de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gascon","sequence":"additional","affiliation":[{"name":"Universidade S\u00e3o Judas Tadeu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Paiva","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Prof. Alberto Antunes \/ Universidade Federal de Alagoas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Galvao-Castro","sequence":"additional","affiliation":[{"name":"Oswaldo Cruz Foundation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thessika","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Centro HTLV\/Escola Bahiana de Medicina e Sa\u00fade P\u00fablica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grassi","sequence":"additional","affiliation":[{"name":"Instituto Gon\u00e7alo Moniz\/ Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00edsa","family":"Sousa","sequence":"additional","affiliation":[{"name":"N\u00facleo de Medicina Tropical\/ Universidade Federal do Par\u00e1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Puccioni-Sohler","sequence":"additional","affiliation":[{"name":"Escola de Medicina e Cirurgia\/UNIRIO; Pos-graduation in infecctious diseases\/ UFRJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youko","family":"Nukui","sequence":"additional","affiliation":[{"name":"Hospital das Cl\u00ednicas da FMUSP\/ Universidade de Sao Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Kashima","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo, Ribeir\u00e3o Preto Medical School, Blood Center of Ribeir\u00e3o Preto, Ribeir\u00e3o Preto, SP, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Dierckx","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8683-705X","authenticated-orcid":false,"given":"Jean-Claude","family":"Twizere","sequence":"additional","affiliation":[{"name":"University of Liege"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Murphy","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bruhn","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-4473","authenticated-orcid":false,"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Claes","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien","family":"Vanderlinden","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[{"name":"University of Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Vercauteren","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Instituto de Medicina Tropical 'Alexander von Humboldt', Universidad Peruana Cayetano Heredia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Lopez","sequence":"additional","affiliation":[{"name":"Instituto de Medicina Tropical 'Alexander von Humboldt', Universidad Peruana Cayetano Heredia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Talledo","sequence":"additional","affiliation":[{"name":"Instituto de Medicina Tropical 'Alexander von Humboldt', Universidad Peruana Cayetano Heredia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gotuzzo","sequence":"additional","affiliation":[{"name":"Instituto de Medicina Tropical 'Alexander von Humboldt', Universidad Peruana Cayetano Heredia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases \u201cEmilio Ribas\u201d \/ Secretaria de Sa\u00fade do Estado de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0857-7683","authenticated-orcid":false,"given":"Isabelle","family":"Cleynen","sequence":"additional","affiliation":[{"name":"KU Leuven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Casseb","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo Medical School - USP"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0140-6736(18)30974-7","article-title":"Time to eradicate HTLV-1: an open letter to WHO","volume":"391","author":"Martin F","year":"2018","unstructured":"Martin F, Tagaya Y, Gallo R (2018) Time to eradicate HTLV-1: an open letter to WHO. Lancet 391:1893\u20131894","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/S2666-5247(21)00330-X","article-title":"Health inequities and HTLV-1","volume":"3","author":"Rosadas C","year":"2022","unstructured":"Rosadas C, Taylor GP (2022) Health inequities and HTLV-1. Lancet Microbe 3:e164","journal-title":"Lancet Microbe"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1473-3099(19)30402-5","article-title":"Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies","volume":"20","author":"Schierhout G","year":"2020","unstructured":"Schierhout G et al (2020) Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis 20:133\u2013143","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3960\/jslrt.17008","article-title":"Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma","volume":"57","author":"Katsuya H","year":"2017","unstructured":"Katsuya H, Ishitsuka K (2017) Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma. J Clin Exp Hematop 57:87\u201397","journal-title":"J Clin Exp Hematop"},{"key":"ref5","author":"Marcusso RMN","year":"2020","unstructured":"Marcusso RMN et al (2020) Dichotomy in fatal outcomes in a large cohort of people living with htlv-1 in s\u00e3o paulo, brazil. Pathogens 9"},{"key":"ref6","first-page":"548","article-title":"[Guide of clinical management of HTLV patient: neurological aspects]","volume":"63","author":"Castro-Costa CM","year":"2005","unstructured":"De Castro-Costa CM et al (2005) [Guide of clinical management of HTLV patient: neurological aspects]. Arq Neuropsiquiatr 63:548\u2013551","journal-title":"Arq Neuropsiquiatr"},{"key":"ref7","article-title":"HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"1","author":"Bangham CRM","year":"2015","unstructured":"Bangham CRM, Araujo A, Yamano Y, Taylor GP (2015) HTLV-1-associated myelopathy\/tropical spastic paraparesis. Nat Rev Dis Primers 1","journal-title":"Nat Rev Dis Primers"},{"key":"ref8","first-page":"20","article-title":"HTLV-1 Infection Still A Neglected Disease - PubMed","volume":"3","author":"Soriano V","year":"2018","unstructured":"Soriano V (2018) HTLV-1 Infection Still A Neglected Disease - PubMed. AIDS Rev 3:20","journal-title":"AIDS Rev"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000487","article-title":"Is human T cell lymphotropic type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM) syndrome a neglected disease?","volume":"3","author":"Casseb J","year":"2009","unstructured":"Casseb J (2009) Is human T cell lymphotropic type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM) syndrome a neglected disease? PLoS Negl Trop Dis 3","journal-title":"PLoS Negl Trop Dis"},{"key":"ref10","article-title":"Increasing awareness of human T-lymphotropic virus type-1 infection: a serious, invisible, and neglected health problem in Brazil","volume":"52","author":"M P-S","year":"2019","unstructured":"M P-S et al (2019) Increasing awareness of human T-lymphotropic virus type-1 infection: a serious, invisible, and neglected health problem in Brazil. Rev Soc Bras Med Trop 52","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2004199118","article-title":"Genome wide association study of HTLV-1-associated myelopathy\/tropical spastic paraparesis in the Japanese population","volume":"118","author":"Penova M","year":"2021","unstructured":"Penova M et al (2021) Genome wide association study of HTLV-1-associated myelopathy\/tropical spastic paraparesis in the Japanese population. Proc Natl Acad Sci U S A 118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/ciy289","article-title":"Early Juvenile Human T-cell Lymphotropic Virus Type-1-Associated Myelopathy\/Tropical Spastic Paraparesis: Study of 25 Patients","volume":"67","author":"Varandas CMN","year":"2018","unstructured":"Varandas CMN et al (2018) Early Juvenile Human T-cell Lymphotropic Virus Type-1-Associated Myelopathy\/Tropical Spastic Paraparesis: Study of 25 Patients. Clin Infect Dis 67:1427\u20131433","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41576-021-00333-z","article-title":"Addressing admixture with Tractor","volume":"22","author":"Clyde D","year":"2021","unstructured":"Clyde D (2021) Addressing admixture with Tractor. Nat Rev Genet 22:134","journal-title":"Nat Rev Genet"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006967","article-title":"Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: Association with high proviral load","volume":"13","author":"Haziot ME","year":"2019","unstructured":"Haziot ME et al (2019) Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: Association with high proviral load. PLoS Negl Trop Dis 13","journal-title":"PLoS Negl Trop Dis"},{"key":"ref15","author":"Marcusso RM","year":"2024","unstructured":"Marcusso RM, do N et al (2024) HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients. Pathogens 13"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","article-title":"Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation","volume":"44","author":"O\u2019Leary NA","year":"2016","unstructured":"O\u2019Leary NA et al (2016) Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res 44:D733\u2013D745","journal-title":"Nucleic Acids Res"},{"key":"ref17","article-title":"Functional capacity of natural killer cells in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM) patients","volume":"19","author":"Queiroz GAN","year":"2019","unstructured":"Queiroz GAN et al (2019) Functional capacity of natural killer cells in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM) patients. BMC Infect Dis 19","journal-title":"BMC Infect Dis"},{"key":"ref18","author":"Nakamura THAM","year":"2023","unstructured":"Nakamura THAM, Pathogenesis (2023) The Transmigration Activity of HTLV-1-Infected T Cells into Tissues. Pathogens 12"},{"key":"ref19","author":"Freitas NL","year":"2022","unstructured":"Freitas NL et al (2022) Lessons from the Cerebrospinal Fluid Analysis of HTLV-1-Infected Individuals: Biomarkers of Inflammation for HAM Development. Viruses 14"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01261-5","article-title":"Functional mapping and annotation of genetic associations with FUMA","volume":"8","author":"Watanabe K","year":"2017","unstructured":"Watanabe K, Taskesen E, Van Bochoven A, Posthuma D (2017) Functional mapping and annotation of genetic associations with FUMA. Nat Commun 8","journal-title":"Nat Commun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1073\/pnas.1423199113","article-title":"The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome","volume":"113","author":"Satou Y","year":"2016","unstructured":"Satou Y et al (2016) The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome. Proc Natl Acad Sci U S A 113:3054\u20133059","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.genhosppsych.2021.08.012","article-title":"Prevalence and factors associated with depression and anxiety in people living with HTLV-1: A systematic review with meta-analysis and meta-regression","volume":"73","author":"Souza LS","year":"2021","unstructured":"Souza LS et al (2021) Prevalence and factors associated with depression and anxiety in people living with HTLV-1: A systematic review with meta-analysis and meta-regression. Gen Hosp Psychiatry 73:54\u201363","journal-title":"Gen Hosp Psychiatry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s13365-020-00905-5","article-title":"Cognitive impairment in the HTLV-1 infection: a comparative study associated with functional performance","volume":"27","author":"Paula JJ","year":"2021","unstructured":"de Paula JJ et al (2021) Cognitive impairment in the HTLV-1 infection: a comparative study associated with functional performance. J Neurovirol 27:849\u2013856","journal-title":"J Neurovirol"},{"key":"ref24","author":"Erickson LD","year":"2021","unstructured":"Erickson LD, Hedges DW, Brown BL, Embley B, Gale SD (2021) Association between Cognitive Function and Depression with Human T-Cell Lymphotropic Virus 1 Seropositivity and Serointensity in UK Adults. Pathogens 10"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1175762","article-title":"EZH1\/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy","volume":"14","author":"Koseki A","year":"2023","unstructured":"Koseki A et al (2023) EZH1\/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy. Front Microbiol 14","journal-title":"Front Microbiol"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002480","article-title":"Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy","volume":"8","author":"Tattermusch S","year":"2012","unstructured":"Tattermusch S et al (2012) Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog 8","journal-title":"PLoS Pathog"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3201\/eid1001.020714","article-title":"Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection","volume":"10","author":"Murphy EL","year":"2004","unstructured":"Murphy EL et al (2004) Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. Emerg Infect Dis 10:109\u2013116","journal-title":"Emerg Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.tim.2012.07.004","article-title":"HTLV-1 infection: what determines the risk of inflammatory disease?","volume":"20","author":"Tattermusch S","year":"2012","unstructured":"Tattermusch S, Bangham CRM (2012) HTLV-1 infection: what determines the risk of inflammatory disease? Trends Microbiol 20:494\u2013500","journal-title":"Trends Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3389\/fmicb.2019.02110","article-title":"Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis","volume":"10","author":"Tamaki K","year":"2019","unstructured":"Tamaki K et al (2019) Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis. Front Microbiol 10:2110","journal-title":"Front Microbiol"},{"key":"ref30","author":"Sato T","year":"2013","unstructured":"Sato T et al (2013) CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis. PLoS Negl Trop Dis 7"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1089\/aid.2016.0296","article-title":"Mediators Go Together: High Production of CXCL9, CXCL10, IFN-\u03b3, and TNF-\u03b1 in HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis","volume":"33","author":"Neco HVPDC","year":"2017","unstructured":"Neco HVPDC et al (2017) Mediators Go Together: High Production of CXCL9, CXCL10, IFN-\u03b3, and TNF-\u03b1 in HTLV-1-Associated Myelopathy\/Tropical Spastic Paraparesis. AIDS Res Hum Retroviruses 33:1134\u20131139","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1416476","article-title":"IL-10 predicts incident neuroinflammatory disease and proviral load dynamics in a large Brazilian cohort of people living with human T-lymphotropic virus type 1","volume":"15","author":"Assone T","year":"2024","unstructured":"Assone T et al (2024) IL-10 predicts incident neuroinflammatory disease and proviral load dynamics in a large Brazilian cohort of people living with human T-lymphotropic virus type 1. Front Immunol 15","journal-title":"Front Immunol"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.12469.2","article-title":"Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1 [version 2; referees: 2 approved, 1 approved with reservations]","volume":"2","author":"Billman MR","year":"2017","unstructured":"Billman MR, Rueda D, Bangham CRM (2017) Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1 [version 2; referees: 2 approved, 1 approved with reservations]. Wellcome Open Res 2","journal-title":"Wellcome Open Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/BRAIN\/AWAE244","article-title":"Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation","author":"Schneider-Hohendorf T","year":"2024","unstructured":"Schneider-Hohendorf T et al (2024) Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation. Brain. 10.1093\/BRAIN\/AWAE244","journal-title":"Brain"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02658-w","article-title":"Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation","volume":"19","author":"Assone T","year":"2022","unstructured":"Assone T et al (2022) Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation. J Neuroinflammation 19","journal-title":"J Neuroinflammation"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.978800","article-title":"HDAC inhibitors Panobinostat and Romidepsin enhance tax transcription in HTLV-1-infected cell lines and freshly isolated patients\u2019 T-cells","volume":"13","author":"Schnell AP","year":"2022","unstructured":"Schnell AP et al (2022) HDAC inhibitors Panobinostat and Romidepsin enhance tax transcription in HTLV-1-infected cell lines and freshly isolated patients\u2019 T-cells. Front Immunol 13","journal-title":"Front Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1182\/blood-2011-04-349910","article-title":"Safety of long-term treatment of HAM patients with valproic acid","volume":"118","author":"Olindo S","year":"2011","unstructured":"Olindo S et al (2011) Safety of long-term treatment of HAM patients with valproic acid. Blood 118:6306\u20136309","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.3390\/v14010136","article-title":"Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P)","volume":"14","author":"Yamauchi J","year":"2022","unstructured":"Yamauchi J et al (2022) Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P). Viruses 14","journal-title":"Viruses"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/ecco-jcc\/jjy162","article-title":"GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD","volume":"13","author":"Dierckx T","year":"2019","unstructured":"Dierckx T, Verstockt B, Vermeire S, Van Weyenbergh J (2019) GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD. J Crohns Colitis 13:389\u2013394","journal-title":"J Crohns Colitis"},{"key":"ref40","article-title":"Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-\u03b2 Response in HTLV-1-Associated Neuroinflammation","volume":"9","author":"Leal FE","year":"2018","unstructured":"Leal FE et al (2018) Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-\u03b2 Response in HTLV-1-Associated Neuroinflammation. Front Microbiol 9","journal-title":"Front Microbiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fimmu.2017.00097","article-title":"A Fashi Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation","volume":"8","author":"Menezes SM","year":"2017","unstructured":"Menezes SM et al (2017) A Fashi Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation. Front Immunol 8:97","journal-title":"Front Immunol"},{"key":"ref42","author":"Weyenbergh J","year":"2014","unstructured":"Van Weyenbergh J et al (2014) Anti-CD3 monoclonal antibody as a possible therapeutic alternative in HAM. Retrovirology 11, O40"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1093\/brain\/awt183","article-title":"Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy","volume":"136","author":"Ando H","year":"2013","unstructured":"Ando H et al (2013) Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. Brain 136:2876\u20132887","journal-title":"Brain"},{"key":"ref44","author":"Sato T","year":"2013","unstructured":"Sato T et al (2013) CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis. PLoS Negl Trop Dis 7"},{"key":"ref45","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103088","article-title":"The role of cholesterol metabolism in multiple sclerosis: From molecular pathophysiology to radiological and clinical disease activity","volume":"21","author":"Lorincz B","year":"2022","unstructured":"Lorincz B, Jury EC, Vrablik M, Ramanathan M, Uher T (2022) The role of cholesterol metabolism in multiple sclerosis: From molecular pathophysiology to radiological and clinical disease activity. Autoimmun Rev 21","journal-title":"Autoimmun Rev"},{"key":"ref46","author":"Futsch N","year":"2018","unstructured":"Futsch N, Prates G, Mahieux R, Casseb J, Dutartre H (2018) Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases. Viruses 10"},{"key":"ref47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010416","article-title":"NK cells and monocytes modulate primary HTLV-1 infection","volume":"18","author":"Moles R","year":"2022","unstructured":"Moles R et al (2022) NK cells and monocytes modulate primary HTLV-1 infection. PLoS Pathog 18","journal-title":"PLoS Pathog"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1182\/blood-2007-11-123430","article-title":"Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease","volume":"111","author":"Grant C","year":"2008","unstructured":"Grant C, Oh U, Yao K, Yamano Y, Jacobson S (2008) Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease. Blood 111:5601\u20135609","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49737-5","article-title":"The tyrosine kinase KDR is essential for the survival of HTLV-1-infected T cells by stabilizing the Tax oncoprotein","volume":"15","author":"Mohanty S","year":"2024","unstructured":"Mohanty S et al (2024) The tyrosine kinase KDR is essential for the survival of HTLV-1-infected T cells by stabilizing the Tax oncoprotein. Nat Commun 15","journal-title":"Nat Commun"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008761","article-title":"Health state utility values in people living with HTLV-1 and in patients with HAM: The impact of a neglected disease on the quality of life","volume":"14","author":"Rosadas C","year":"2020","unstructured":"Rosadas C et al (2020) Health state utility values in people living with HTLV-1 and in patients with HAM: The impact of a neglected disease on the quality of life. PLoS Negl Trop Dis 14:1\u201314","journal-title":"PLoS Negl Trop Dis"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5960764\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5960764\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:53:50Z","timestamp":1745906030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5960764\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":50,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5960764\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,4,29]]},"subtype":"preprint"}}